Longitudinal changes in body composition during palliative systemic chemotherapy and survival outcomes in metastatic colorectal cancer

Figure 4 Baseline status and changes in body composition and their association with survival after the last systemic chemotherapy. A: Sarcopenia; B: Myosteatosis; C: Visceral obesity; D: Subcutaneous obesity. Decrease in the sarcopenia and myosteatosis indices, visceral fat, and subcutaneous fat were defined as sarcopenia T-scores < -0.5, myosteatosis T-scores < -0.5, visceral fat area < -20%, subcutaneous fat area index < -15%, respectively. ScO: Subcutaneous obesity; mo: Months; VO: Visceral obesity; HR: Hazard ratio.